Palmitoylethanolamide (PEA) reduces sensitivity to pain in the central and peripheral nervous systems and increases pain modulation, says a recent study from Austrian researchers.
Palmitoylethanolamide (PEA) may reduce inflammation and optimise immune responses to infectious conditions such as Covid-19, according to researchers in the USA.
Eight weeks of supplementation with palmitoylethanolamide, an endocannabinoid-like molecule, may improve sleep measures in healthy adults, according to results of a double-blind, randomized, placebo-controlled study.
During these unprecedented times, many are undergoing a great amount of stress, leading many to seek out natural products to manage stress and boost their mood.
